Latest Myocor Inc. Stories
Myocor, Inc. announced that its percutaneous iCoapsys™ device was successfully implanted by Dr. Wes Pedersen, an interventional cardiologist with the Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, on May 7, 2008. iCoapsys is one of two Myocor devices designed to treat patients with mitral valve insufficiency caused by heart failure and coronary artery disease (CAD). It is the subject of the Valvular and Ventricular Improvement Via iCoapsys Delivery...
- A stinking tobacco.
- Offal; waste animal product; organic matter unfit for consumption.